Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. First patient receives Pixium bionic vision implant
Pixium Vision said today that the 1st patient in the UK was implanted with its IRIS II bionic vision system.
The epi-retinal implant has 150 electrodes and a bio-inspired camera intended for patients who have lost sight due to retinitis pigmentosa. Read more
4. St. Jude wins CE Mark for MRI safe labeling for Quadra CRT-P
St. Jude Medical said today it won CE Mark approval in the European Union to add magnetic resonance imaging conditional labeling to its Quadra Allure MP cardiac resynchonization therapy pacemaker.
The company’s Quadra Allure MP CRT-P is now cleared as operable with diagnostic MRI scans of up to 1.5 Tesla, the St. Paul, Minn.-based company said. Read more
3. Abbott wins Japanese approval for Absorb
Abbott said today it won approval from the Japanese Ministry of Health, Labor and Welfare for its Absorb bioresorbable heart stent, touting it as the 1st fully dissolving heart stent approved in the country.
The stent is now cleared for use in patients with coronary artery disease, the Chicago-based company said, with approval coming supported by the company’s Absorb Japan study of the device. Read more
2. Boston Scientific, University of Alabama settle CRM patent spat
Boston Scientific and the University of Alabama settled a patent dispute over cardiac rhythm management technology.
The spat spans back to 2014, when the University of Alabama at Birmingham and the UAB Research Foundation filed a lawsuit against Boston Scientific and Cardiac Pacemakers, saying that the companies infringed on its patent by making, using, offering and selling cardiac resynchronization therapy defibrillators. Read more
1. Medtronic joins Masimo CEO Kiani’s Patient Safety Foundation, pledges $5m
Despite being rivals in the blood oxygen diagnostic fields, Medtronic said it is joining Masimo CEO Joe Kiani’s Patient Safety Movement Foundation with a $5 million, 5-year commitment.
By joining the program, Medtronic will provide $5 million over 5 years and share anonymized data from its medical devices to help develop analytic programs to help improve patient safety, according to a Patient Safety Movement Foundation release. Read more
